Camrelizumab and apatinib in Chinese patients with locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer: an exploratory open-label, single-arm trial

Authors

Xinqi Cheng (ORCID: https://orcid.org/0000-0001-8228-5078)
Di Sun (ORCID: https://orcid.org/0000-0001-9039-1022)
Zhuanzhuan Mu (ORCID: https://orcid.org/0009-0006-6833-5765)
Chao Meng (ORCID: https://orcid.org/0000-0001-6720-1307)
Jun Liang (ORCID: https://orcid.org/0000-0001-8328-5168)
Cong Shi (ORCID: https://orcid.org/0000-0001-9474-2686)
Yingqiang Zhang (ORCID: https://orcid.org/0000-0003-0945-7405)
Xin Zhang (ORCID: https://orcid.org/0000-0001-5468-6210)
Yansong Lin
Xing Wei (ORCID: https://orcid.org/0000-0003-0998-4862)
Yuqing Sun

Institutions

Capital Medical University (CN)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Peking University (CN)
Peking Union Medical College Hospital (CN)
First Affiliated Hospital of Xi'an Jiaotong University (CN)
Peking University People's Hospital (CN)
Peking University International Hospital (CN)
Beijing Tsinghua Chang Gung Hospital (CN)

Publication Details

Journal: BMC Medicine
Published: 2025-12-18
DOI: https://doi.org/10.1186/s12916-025-04550-9
Primary Topic: Thyroid Cancer Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Camrelizumab and apatinib in Chinese patients with locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer: an exploratory open-label, single-arm trial

Xinqi Cheng, Di Sun, Zhuanzhuan Mu, Chao Meng et al.

Dec 18, 2025

BMC Medicine

Thyroid Cancer Diagnosis and Treatment

article

Camrelizumab and apatinib in Chinese patients with locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer: an exploratory open-label, single-arm trial

Xinqi Cheng, Di Sun, Zhuanzhuan Mu, Chao Meng, Jun Liang, Cong Shi, Yingqiang Zhang, Xin Zhang, Yansong Lin, Xing Wei, Yuqing Sun

December 18, 2025article en

Abstract

No abstract available for this paper.

BMC MedicineVol. 24(1)

Capital Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking University (CN), Peking Union Medical College Hospital (CN), First Affiliated Hospital of Xi'an Jiaotong University (CN), Peking University People's Hospital (CN), Peking University International Hospital (CN), Beijing Tsinghua Chang Gung Hospital (CN)

Openalex Percentile: Top 47%

Thyroid Cancer Diagnosis and Treatment

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.